Catarina Madeira

Ms. Catarina Madeira

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2017 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
Maria BernardoMaria Bernardo
Maria Bernardo
CMCatarina Madeira
Catarina Madeira
NNNuno Carlos Lapa dos Santos Nunes
Nuno Carlos Lapa dos Santos Nunes
DDDiogo André Costa Messias Dias
Diogo André Costa Messias Dias
DGDelfina Maria Barbosa Godinho
Delfina Maria Barbosa Godinho
IFIsabel Fonseca
Isabel Fonseca

24 June 2020 in Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
RSRaquel dos Santos
Raquel dos Santos
IIInês Iria
Inês Iria
AMAna M. Manuel
Ana M. Manuel
ALAna P. Leandro
Ana P. Leandro
CMCatarina Madeira
Catarina Madeira
CRCecilia Roque
Cecilia Roque

19 January 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
VBValentina Barcherini
Valentina Barcherini
JLJoana Loureiro
Joana Loureiro
ASAna Margarida Ribeiro Sena
Ana Margarida Ribeiro Sena
CMCatarina Madeira
Catarina Madeira
PLPaula Leandro
Paula Leandro
Maria SantosMaria Santos
Maria Santos
For the first time, the pharmacokinetic (PK) profile of tryptophanol-derived isoindolinones, previously reported as p53 activators, was investigated. From the metabolites’ identification, performed by liquid chromatography coupled to high resolution tandem mass spectrometry (LC-HRMS/MS), followed by their preparation and structural elucidation, it was possible to identify that the indole C2 and C3 are the main target of the cytochrome P450 (CYP)-promoted oxidative metabolism in the tryptophanol-derived isoindolinone scaffold. Based on these findings, to search for novel p53 activators a series of 16 enantiopure tryptophanol-derived isoindolinones substituted with a bromine in indole C2 was prepared, in yields of 62–89%, and their antiproliferative activity evaluated in human colon adenocarcinoma HCT116 cell lines with and without p53. Structural optimization led to the identification of two (S)-tryptophanol-derived isoindolinones 3.9-fold and 1.9-fold more active than hit SLMP53-1, respectively. Compounds’ metabolic stability evaluation revealed that this substitution led to a metabolic switch, with the impact of Phase I oxidative metabolism being minimized. Through differential scanning fluorimetry (DSF) experiments, the most active compound of the series in cell assays led to an increase in the protein melting temperature (Tm) of 10.39 °C, suggesting an effective binding to wild-type p53 core domain.